Volume 27, Number 7—July 2021
CME ACTIVITY - Research
Non–C. difficile Clostridioides Bacteremia in Intensive Care Patients, France
Table 2
Clinical and biologic characteristics of patients with Closteridiodes bacteremia, France*
Characteristic | All patients, n = 135 |
Survived, n = 65 |
Died in ICU, n = 70 |
|||||
---|---|---|---|---|---|---|---|---|
No. | Result | No. | Result | No. | Result | |||
Temperature |
75 |
37 (36–39) |
30 |
38.5 (37.3–39) |
45 |
37 (35.6–38.7) |
||
Clinical manifestations associated with bacteremia at ICU admission | ||||||||
Septic shock | 115 | 85% | 49 | 75% | 66 | 94% | ||
Digestive symptoms | 84 | 62% | 42 | 65% | 42 | 60% | ||
Acute respiratory failure | 41 | 30% | 15 | 23% | 26 | 37% | ||
Coma | 38 | 28% | 6 | 9% | 32 | 46% | ||
Cardiac arrest | 26 | 19% | 2 | 3% | 24 | 34% | ||
Myonecrosis |
21 |
16% |
11 |
17% |
10 |
14% |
||
Prognostic scores at ICU admission | ||||||||
Charlson score | 135 | 5 (3–6) | 65 | 5 (2–7) | 70 | 4.5 (3–6) | ||
SAPS2 score | 106 | 63 (44–88) | 47 | 45 (33–57) | 59 | 82 (63–97) | ||
SOFA score |
105 |
10 (7–14) |
47 |
8 (5–10) |
58 |
12 (9–15) |
||
Organ support in ICU | ||||||||
Vasopressors, n = 132 | 108 | 82% | 42 | 66% | 66 | 97% | ||
Mechanical ventilation, n = 133 | 105 | 79% | 41 | 63% | 64 | 94% | ||
Renal-replacement therapy, n = 131 |
44 |
34% |
17 |
26% |
27 |
41% |
||
Biologic parameters at ICU admission | ||||||||
Leukocytes, × 109/L | 97 | 9.5 (2.8–17.8) | 49 | 9.5 (6.1–20.2) | 48 | 9.3 (1.6–16.0) | ||
Platelets, × 109/L | 93 | 141 (76–214) | 45 | 143 (73–217) | 48 | 138 (84–206) | ||
Hemoglobin, g/dL | 92 | 10.3 (7.8–12.2) | 45 | 10.2 (8.8–12.2) | 47 | 10.3 (7.0–11.9) | ||
Hemolysis, n = 130 |
22 |
17% |
6 |
9% |
16 |
24% |
||
Acute renal failure, n = 107 | ||||||||
KDIGO classification 1 | 14 | 13% | 10 | 20% | 4 | 7% | ||
KDIGO classification 2 | 34 | 32% | 19 | 38% | 15 | 26% | ||
KDIGO classification 3 |
59 |
55% |
21 |
42% |
38 |
67% |
||
Other | ||||||||
Aspartate aminotransferase, UI/L | 80 | 92 (41–269) | 38 | 71 (41–172) | 42 | 134 (44–346) | ||
Alanine aminotransferase, UI/L | 81 | 54 (25–142) | 39 | 47 (21–125) | 42 | 69 (27–152) | ||
Bilirubin, µmol/L | 69 | 22 (10–45) | 34 | 27 (10.3–52.3) | 35 | 19.5 (10.5–35.7) | ||
Lactatemia, mmol/L | 93 | 5.3 (2.3–8.8) | 40 | 3.2 (1.5–5.2) | 53 | 8 (4.9–12) | ||
pH | 93 | 7.29 (7.13–7.4) | 40 | 7.38 (7.32–7.43) | 53 | 7.18 (7.05–7.31) |
*Results are given as percentages or median (interquartile range). ICU, intensive care unit; KDIGO, Kidney Disease: Improving Global Outcomes (https://kdigo.org); SAPS2, simplified acute physiology score (SAPS2); SOFA, sequential organ failure assessment.